As of early 2026, GLP-1 receptor agonists have treated tens of millions worldwide ( [153] ), and that number is rapidly growing as new indications expand
More is not always better, and adding too much fiber too quickly can make some people feel worse
Long-term safety is one of the primary objectives
Moderate weight loss was found to be a common side effect of the drug, and the FDA approved a different formulation of semaglutide, called Wegovy, for that purpose in 2021 .Ho and Petrou said the different formulations of semaglutide could help explain why it has led to so many more overdoses than other drugs of its class
albicans The trained immunity is driven by epigenetic reprogramming and metabolic rewiring of innate immune cells upon primary stimulation with microbial components, cytokines or other stimuli
Many people feel less driven to eat and more satisfied with smaller portions